Merck & Co., Inc. (MRK)
NYSE: MRK · IEX Real-Time Price · USD
127.72
-0.18 (-0.14%)
At close: Jul 2, 2024, 4:00 PM
129.00
+1.28 (1.00%)
After-hours: Jul 2, 2024, 7:57 PM EDT
Merck & Co. Market Cap
Merck & Co. has a market cap or net worth of $323.49 billion as of July 2, 2024. Its market cap has increased by 11.25% in one year.
Market Cap
323.49B
Enterprise Value
352.09B
1-Year Change
11.25%
Ranking
Category
Stock Price
$127.72
Market Cap Chart
Since December 1, 1998, Merck & Co.'s market cap has increased from $187.00B to $323.49B, an increase of 72.99%. That is a compound annual growth rate of 2.16%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 323.95B | 17.26% |
Dec 29, 2023 | 276.26B | -1.79% |
Dec 30, 2022 | 281.30B | 45.31% |
Dec 31, 2021 | 193.59B | -6.46% |
Dec 31, 2020 | 206.96B | -10.62% |
Dec 31, 2019 | 231.56B | 16.54% |
Dec 31, 2018 | 198.69B | 29.61% |
Dec 29, 2017 | 153.30B | -5.55% |
Dec 30, 2016 | 162.31B | 10.00% |
Dec 31, 2015 | 147.55B | -8.86% |
Dec 31, 2014 | 161.90B | 10.71% |
Dec 31, 2013 | 146.24B | 17.50% |
Dec 31, 2012 | 124.46B | 8.31% |
Dec 30, 2011 | 114.91B | 3.49% |
Dec 31, 2010 | 111.03B | 44.07% |
Dec 31, 2009 | 77.07B | 19.91% |
Dec 31, 2008 | 64.27B | -49.18% |
Dec 31, 2007 | 126.48B | 33.62% |
Dec 29, 2006 | 94.66B | 36.08% |
Dec 30, 2005 | 69.56B | -2.41% |
Dec 31, 2004 | 71.27B | -30.66% |
Dec 31, 2003 | 102.79B | -19.14% |
Dec 31, 2002 | 127.12B | -4.96% |
Dec 31, 2001 | 133.75B | -38.06% |
Dec 29, 2000 | 215.92B | 37.49% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 861.74B |
Novo Nordisk | 628.28B |
UnitedHealth Group | 458.57B |
Johnson & Johnson | 351.45B |
AbbVie | 293.06B |
AstraZeneca | 238.71B |
Novartis AG | 208.25B |
Thermo Fisher | 203.81B |